Financials

  • Market Capitalization 854.65 M
  • Employee 29
  • Founded 2018
  • CEO N/A
  • Website www.climbbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZNKL0K6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.55
Relación precio/flujo de caja
-932.13

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2525
TBPH
Theravance Biopharma, Inc. - Ordinary Shares
17.04 USD0.00%+0.41%+0.95%+18.75%884.70 M USD
2557
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
46.42 USD-0.94%+0.80%+20.32%+54.07%867.12 M USD
2590
ACHV
Achieve Life Sciences, Inc. - Common Shares
8.06 USD-1.47%+1.51%+30.21%+152.66%829.39 M USD
2598
PHAR
Pharming Group N.V. - ADS, each representing 10
11.68 USD-1.43%-1.93%-8.46%-22.03%819.56 M USD